Overview

Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler

Status:
Completed

Trial end date:
2012-07-01

Target enrollment:

Participant gender:

Summary

This is an open-Label, Randomized Study in Healthy Normal Volunteers looking at exposure and effects (PK/PD) of multiple doses of Technosphere® Insulin (TI) using the Gen2C inhaler.

Phase:

Phase 1

Details

Lead Sponsor:

Mannkind Corporation

Treatments:

Insulin
Insulin, Globin Zinc